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• Cardiac Implantable Electronic Devices (CIED) are used to regulate a 
patient’s heartbeat when arrhythmia is present
• Indications for lead extraction include lead and pocket infection, lead 
fracture, skin erosion, recalled lead, lead migration or dislodgement
• Due to binding tissue that can form around the leads if implanted for 
multiple years, extraction can be challenging.  An understanding of 
complication risk factors is beneficial for optimal CIED management and 
lead extraction decision making 
Table 4: Risk Factors and Respective Complication Rates
Risk Factor Patients Subset Population
ICD Device Extraction 15.3% (20) 131
Extraction Due to 
Infection
18.0% (14) 78
3+ Leads Extracted 20.0% (8) 40
*Leads >5 Years Old 12.5% (6) 48




*High Risk Cohort 16.7% (8) 60
Table 3: Mortality Rate
Perioperative 3.1% (6)
30 Day 4.1% (8)






Outcomes of Implantable Cardioverter Defibrillator (ICD)/Pacing Lead Extraction 
Over 8 Years
Retrospective study of 195 adult patients with the discharge condition of lead 
extraction treated at LVHN CC over an eight year period, from 2011 to 2018.
1. Gain a better understanding of LVHN Lead-Extraction Patient Population.
2. Determine any correlation between identified risk factors and survivability.
3. Analyze Complication and Mortality Rates (Perioperative, 30 Day, Yearly)
4. Evaluate overall intraoperative and postoperative outcomes.
Conclusions
• Patients in increased risk subsets (Infection as Extraction Indication; 3+ 
Leads Extracted) have a significantly lower survivability rate than those in 
the general population
• LVHN Lead Extraction Patients have a higher age and high risk demographic, 
however mortality and complication rates are kept low 
• Age: >75 Years 37.4%
• High Risk: >2 Comorbidities 69.7%
• Complication Rate: 15.4%
• Perioperative Mortality Rate: 3.1%
• Future Steps:
• Further Exploration Within Significant Risk Factor Subsets
• Infection Prevention and Awareness: Antibiotic Envelope/Emerging 
Leadless Tech
Table 1: Population Demographics
Age (Mean, SD) 67.19 (15.28) Chronic Renal Disease 60 (39.5%)
> 75 73 (37.4%) On Dialysis 13 (6.7%)
Male 133 (68.2%) Peripheral Vascular Disease (PVD) 28 (15.4%)
Female 59 (30.3%) Previous Cerebrovascular Accident (CVA) 19 (12.8%)
ICD Device 131 (68.2%) Hypertension 142 (72.8%)
Pacemaker Device 64 (32.8%) Previous Myocardial Infarction (MI) 43 (25.1%)
Current Tobacco Use 26 (13.3%) Previous Open Heart Surgery (OHS) 51 (26.2%)
Anticoagulents 109 (55.9%) Anemia 49 (30.8%)
Ejection Fraction <50% 106 (54.4%) Chronic Obstructive Pulmonary Disease COPD) 42 (22.1%)
Diabetes Mellitus 77 (42.6%) Coronary Artery Disease (CAD) 104 (72.8%)
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• Build Lead Extraction Database
• REDCap
2
• Configure Relevant Data for Analysis
• Epic, OnBase EHMR
3
• Create Kaplan-Meier Survivability Curve
• Excel, XLStat
*A High Risk cohort of 48 patients was established using the following criteria: 75+ years of age; >2 comorbidities.





Survival Rate for Each 
Group is Unequal
“3+ Leads Extracted” and 
“Extraction Due to 
Infection” Has a Significant 
Effect On Patients’ 
Survivability
Results
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P-value=0.0016 P-value=0.0028
